Published in J Clin Microbiol on October 01, 1994
Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol (2011) 1.60
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol (2004) 1.56
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol (2005) 1.03
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol (1969) 4.99
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A (1967) 1.82
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Enzyme-linked immunosorbent assay (ELISA): a practical tool for rapid diagnosis of viruses and other infectious agents. Yale J Biol Med (1980) 1.75
Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E. J Clin Microbiol (1980) 1.73
Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol (1970) 1.66
Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis (1974) 1.62
Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly. Epidemiol Infect (1990) 1.49
Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population. Am J Epidemiol (1971) 1.44
Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Dis (1969) 1.41
Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology (1992) 1.32
Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science (1980) 1.29
Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol (1992) 1.25
Growth and intracellular development of a new respiratory virus. J Virol (1967) 1.23
Epidemiology of coronavirus respiratory infections. Arch Dis Child (1983) 1.19
Some characteristics of hemagglutination of certain strains of "IBV-like" virus. J Infect Dis (1969) 1.14
Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis (1980) 1.14
Enzyme-linked immunosorbent assay for coronaviruses HCV 229E and MHV 3. J Gen Virol (1980) 1.10
Virologic studies of acute respiratory disease in young adults. V. Coronavirus 229E infections during six years of surveillance. Am J Epidemiol (1972) 1.05
Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis (1978) 0.99
Occurrence and frequency of coronavirus infections in humans as determined by enzyme-linked immunosorbent assay. Infect Immun (1982) 0.99
Human enteric coronaviruses: antigenic relatedness to human coronavirus OC43 and possible etiologic role in viral gastroenteritis. J Infect Dis (1985) 0.87
Antibodies to human coronaviruses 229E and OC43 in the population of C.R. Acta Virol (1990) 0.83
Rises in titers of antibody to human coronaviruses OC43 and 229E in Seattle families during 1975-1979. Am J Epidemiol (1986) 0.83
Antigenic characterization of human coronaviruses 229E and OC43 by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 0.82
Prevalence of antibody to human coronaviruses 229E, OC43 and neonatal calf diarrhea coronavirus (NCDCV) in patients of Northern Italy. Eur J Epidemiol (1986) 0.82
Diagnosis of human coronavirus infections in children using enzyme-linked immunosorbent assay. J Med Virol (1983) 0.79
Epidemiological study of enteric coronavirus excretion by an enzyme-linked immunosorbent assay. J Med Assoc Thai (1989) 0.78
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol (1970) 4.12
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med (1999) 3.98
Interpandemic influenza in the Houston area, 1974-76. N Engl J Med (1978) 3.92
Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 3.50
Immunity to influenza in man. Annu Rev Microbiol (1983) 3.22
Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol (1979) 3.05
Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics (1983) 3.00
Ribavirin small-particle aerosol treatment of influenza. Lancet (1981) 2.91
Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis (1997) 2.78
Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus. J Clin Microbiol (1996) 2.77
Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis (1974) 2.66
Assessment of experimental and natural viral aerosols. Bacteriol Rev (1966) 2.64
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children. J Clin Microbiol (1993) 2.50
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol Rev (1966) 2.41
Sporadic occurrence of zoonotic swine influenza virus infections. J Clin Microbiol (1984) 2.24
Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun (1977) 2.24
Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis (1971) 2.13
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis (1996) 2.12
Evaluation of a degenerate primer for the PCR detection of human caliciviruses. Arch Virol (1996) 2.11
The role of nasal secretion and serum antibody in the rhinovirus common cold. Am J Epidemiol (1966) 2.11
Protein composition of nasal secretion during respiratory virus infection. Proc Soc Exp Biol Med (1965) 2.03
Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genes. Virology (1987) 1.98
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine (1997) 1.95
A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparation. J Infect Dis (2000) 1.81
Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol (1998) 1.80
Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J Clin Microbiol (1997) 1.77
Real-time RT-PCR for norovirus screening in shellfish. J Virol Methods (2005) 1.75
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol (1980) 1.74
The influenza herald wave. Am J Epidemiol (1982) 1.74
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73
Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans. J Clin Microbiol (1977) 1.73
Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun (1973) 1.72
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1996) 1.71
Immunofluorescent diagnosis of acute viral infection. South Med J (1975) 1.71
Bacterial spinal epidural abscess. Review of 43 cases and literature survey. Medicine (Baltimore) (1992) 1.71
Effects of tetracycline on leukotaxis. J Infect Dis (1974) 1.69
Dual respiratory virus infections. Clin Infect Dis (1997) 1.67
Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens. J Clin Microbiol (2000) 1.66
Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis (2000) 1.66
Distribution of Norwalk virus within shellfish following bioaccumulation and subsequent depuration by detection using RT-PCR. J Food Prot (1998) 1.66
Influenza: its control in persons and populations. J Infect Dis (1986) 1.65
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis (1993) 1.65
Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J Infect Dis (1976) 1.64
Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob Agents Chemother (1980) 1.61
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol (1994) 1.61
Detection and analysis of a small round-structured virus strain in oysters implicated in an outbreak of acute gastroenteritis. Appl Environ Microbiol (1996) 1.60
Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum. J Immunol (1967) 1.59
Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child (1990) 1.56
Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med (2001) 1.55
Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med (1998) 1.55
The effects of influenza on host defenses. J Infect Dis (1981) 1.54
Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.53
Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) (1983) 1.50
Protein interactions during coronavirus assembly. J Virol (1997) 1.49
Right ventricular function and exercise performance late after primary repair of tetralogy of Fallot with the transannular patch in infancy. Am J Cardiol (1998) 1.49
Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man. J Immunol (1970) 1.49
Pneumatosis intestinalis in two infants with rotavirus gastroenteritis. Pediatr Radiol (1991) 1.47
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. Rev Infect Dis (1983) 1.46
Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg (Lond) (1981) 1.44
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol. Antimicrob Agents Chemother (1984) 1.43
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med (1991) 1.43
Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84. Antimicrob Agents Chemother (1985) 1.43
Ventriculoperitoneal shunt infection due to Listeria monocytogenes. Clin Infect Dis (1994) 1.42
Diagnosis of herpes simplex virus infection by immunofluorescence. J Clin Microbiol (1976) 1.42
Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant (1994) 1.42
Reinfection with influenza A (H3N2) virus in young children and their families. J Infect Dis (1979) 1.41
Host protein interactions with the 3' end of bovine coronavirus RNA and the requirement of the poly(A) tail for coronavirus defective genome replication. J Virol (2000) 1.40
Communications. Antigenic relationship between the equine and the Hong Kong human variant of influenza type A2 virus. J Immunol (1969) 1.40
Amantadine therapy of epidemic influenza a(2) (Hong Kong). Infect Immun (1970) 1.39
Effects of rhinovirus infection of pulmonary function of healthy human volunteers. Am Rev Respir Dis (1976) 1.37
Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother (1997) 1.37
Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol (1991) 1.36
Homologous and heterologous resistance to rhinovirus common cold. Am J Epidemiol (1965) 1.36
Experimental infection in man and horses with influenza A viruses. Bull World Health Organ (1969) 1.35
The 9-kDa hydrophobic protein encoded at the 3' end of the porcine transmissible gastroenteritis coronavirus genome is membrane-associated. Virology (1992) 1.35
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers. Infect Immun (1978) 1.30
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis (1998) 1.28
Airborne transmission of respiratory infection with coxsackievirus A type 21. Am J Epidemiol (1970) 1.28
The common cold: control? J Infect Dis (1984) 1.28
Interferon and resistance to upper respiratory virus illness. Proc Soc Exp Biol Med (1969) 1.27